Skip to content

13F-HR/A filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2022-12-31, filed 2023-11-08, with 4 holding rows worth $432,386.

Accession
0001697013-23-000034
Filed
2023-11-08
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, amendment of type new holdings, 4 entries on the cover page, a total value of $432,386 stated on the cover page (in dollars after the unit check, H1), rows summing to $432,386 with VALUE read as dollars as filed, 13F file number 028-18369. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ELEDON PHARMACEUTICALS INC28617k101COM67,743$154,454dollars as filed
SONIDA SENIOR LIVING INC140475203COMMON STOCK11,791$147,388dollars as filed
CATALENT INC USD 0.01148806102COM2,000$90,020dollars as filedcall
BOLT BIOTHERAPEUTICS INC097702104COM31,172$40,524dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001655789-23-000002 superseded2023-02-14acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000033 base2023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000034this filing2023-11-08acceptance time not in the bulk data set